Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12151
PUT
SkinHealth Systems
SKIN
$91.3M
| $51.1K | ﹤0.01% |
25,700
+12,400
| +93% | +$25.2K |
|
12152
CALL
Hyliion Holdings
HYLN
$736M
| $51K | ﹤0.01% |
25,900
-64,100
| -71% | -$107K |
|
12153
PUT
Upland Software
UPLD
$13.4M
| $51K | ﹤0.01% |
2,150
-1,460
| -40% | -$33.2K |
|
|
ADIL
12154
Adial Pharmaceuticals
ADIL
$8.67M
| $50.8K | ﹤0.01% |
+5,752
| New | +$56.1K |
|
|
IVF
12155
INVO Fertility Inc
IVF
$1.86M
| $50.8K | ﹤0.01% |
+1,671
| New | +$107K |
|
|
PVL
12156
Permianville Royalty Trust
PVL
$57.4M
| $50.7K | ﹤0.01% |
+28,028
| New | +$52.7K |
|
12157
CALL
Companhia Siderúrgica Nacional
SID
$1.28B
| $50.7K | ﹤0.01% |
33,800
-79,400
| -70% | -$114K |
|
|
FTRK
12158
Fast Track Group
FTRK
$6.98M
| $50.6K | ﹤0.01% |
+92,086
| New | +$53.4K |
|
|
APLT
12159
CALL
DELISTED
Applied Therapeutics
APLT
| $50.6K | ﹤0.01% |
83,600
-46,200
| -36% | -$21.8K |
|
12160
YieldMax MRNA Option Income Strategy ETF
MRNY
$113M
| $50.5K | ﹤0.01% |
2,852
+882
| +45% | +$18.3K |
|
|
AIOS
12161
AIOS Tech
AIOS
$37M
| $50.4K | ﹤0.01% |
648
-1,102
| -63% | -$85.9K |
|
12162
Elutia
ELUT
$37.9M
| $50.4K | ﹤0.01% |
+56,604
| New | +$105K |
|
12163
PUT
The Oncology Institute
TOI
$513M
| $50.3K | ﹤0.01% |
+14,400
| New | +$49.3K |
|
|
MKDW
12164
MKDWELL Tech Inc
MKDW
$48.8M
| $50.2K | ﹤0.01% |
+7,785
| New | +$50.2K |
|
|
YQ
12165
17 Education & Technology Group
YQ
$21.1M
| $50.2K | ﹤0.01% |
11,726
-26,433
| -69% | -$64.7K |
|
|
PROF
12166
Profound Medical
PROF
$297M
| $50.2K | ﹤0.01% |
10,073
-36,237
| -78% | -$185K |
|
12167
CALL
KLX Energy Services
KLXE
$43.7M
| $50.1K | ﹤0.01% |
+26,100
| New | +$48.7K |
|
12168
CALL
MacroGenics
MGNX
$254M
| $50.1K | ﹤0.01% |
29,800
-5,100
| -15% | -$8.26K |
|
|
RENX
12169
RenX Enterprises
RENX
$5.28M
| $50K | ﹤0.01% |
+1,867
| New | +$43.6K |
|
|
CARV
12170
DELISTED
Carver Bancorp
CARV
| $50K | ﹤0.01% |
+20,933
| New | +$44.2K |
|
12171
PUT
Annexon
ANNX
$880M
| $50K | ﹤0.01% |
16,400
-19,600
| -54% | -$48.7K |
|
12172
CALL
Definitive Healthcare
DH
$72.1M
| $49.9K | ﹤0.01% |
12,300
-6,600
| -35% | -$26.4K |
|
12173
PUT
Zentalis Pharmaceuticals
ZNTL
$344M
| $49.8K | ﹤0.01% |
33,000
+11,000
| +50% | +$16.5K |
|
12174
CALL
Alector
ALEC
$171M
| $49.7K | ﹤0.01% |
16,800
-13,000
| -44% | -$28.6K |
|
|
NVNO
12175
enVVeno Medical
NVNO
$7.39M
| $49.7K | ﹤0.01% |
1,566
+735
| +88% | +$75.1K |
|
Similar funds
Citadel Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Citadel Advisors held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors's Q3 2025 filing shows 2,292 new, 5,365 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Citadel Advisors's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Citadel Advisors fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Citadel Advisors's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Citadel Advisors opened 2,292 new positions and closed 1,963 in Q3 2025.
- Citadel Advisors's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.